Coronary revascularization in ischemic cardiomyopathy

Surgical Clinics of North America

Volumn 84, Issue 1, 2004, Pages 179-199

  Westaby, Stephen ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; CELL VIABILITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MYOCARDIAL HIBERNATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; REVIEW;

EID: 1242271340     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(03)00207-X     Document Type: Review

References (68)

1. Califf R.M., Adams K.F., McKenna W.J., et al. A randomised controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomised Survival Trial (FIRST). Am Heart J. 134:1997;44-54.
2. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Co-operative Scandanavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 316:1987;1429-1435.
3. Deng M.C., De Meester J.M.J., Smits J.M.A., et al. Effect of receiving a heart transplant: analysis of a national cohort entered onto a waiting list, stratified by heart failure severity. BMJ. 321:2000;540-545.
4. Lee K.S., Marwick T.H., Cook S.A., et al. Prognosis of patients with left-ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation. 90:1994;2687-2694.
5. Braunwald E., Klorer R.A. The stunned myocardium: prolonged, postischaemic ventricular dysfunction. Circulation. 86:1992;1146-1149.
6. Rahimtoola S.H. The hibernating myocardium. Am Heart J. 117:1989;211-221.
7. Montalescott G., Faraggi M., Drobinski G., et al. Myocardial viability in patients with Q wave nyocardial infarction and no residual ischemia. Circulation. 86:1992;47-55.
8. Braunwald E., Hollingsworth C., Passamani E. NHLBI workshop on surgery in the treatment of coronary artery disease. Sept 1984. Bethesda, Maryland. Circulation. 72:(Suppl V):1985;1-168.
9. Hearse D.J., Bolli R. Reperfusion induced injury: manifestations, mechanism and clinical relevance. Cardiovasc Res. 26:1992;101-108.
10. Adams J.N., Norton M., Trent R., et al. Hibernating myocardium after acute myocardial infarction treated with thrombolysis. Heart. 75:1996;422-426.
11. Ross J. Jr. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation. 83:1991;1076-1083.
12. Uren N.G., Melin J.A., De Bruyne W., et al. Relation between myocardial blood flow and the severity of coronary artery stenosis. New Engl J Med. 23:1994;1782-1788.
13. Schwarz E.R., J Schaper J., vom Dahl C., et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol. 27:1996;1577-1585.
14. Rinaldi C.A., Masani N.D., Linka A.Z., et al. Effect of repetitive episodes of exercise induced myocardial ischemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning? Heart. 81:1999;404-411.
15. Gerber B.L.J.L., Vanoverschelde J.L., Bol A., et al. Myocardial blood flow, glucose uptake and recruitment of inotropic reserve in chronic left ventricular ischaemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation. 94:1994;651-659.
16. Fallavollita J.A., Perry B.J., Canty J.M. Jr. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation. 95:1995;1900-1909.
17. Bolli R.J.F., Jeroudi M.O. Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence of microvascular stunning. Circulation. 67:1990;332-343.
18. Kalra D.K., Zhy X., Ramchandani M.K., et al. Increased myocardial gene expression of tumour necrosis factor-alpha and iNOS2. A potential mechanism for depressed myocardial function in hibernating myocardium in man. Circulation. 105:2002;1537-1540.
19. Oral H., Dorn G.W., Mann D.L. Sphingosine mediates the immediate negative inotropic effects of tumour necrosis factor - alpha in the adult mammalian cardiac myocyte. J Biol Chem. 272:1997;4842-4856.
20. Ungureanu-longrois D., Balligard J.L., Simmons W.W., et al. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta- adrenergic agonists. Circ Res. 84:1999;1020-1031.
21. Liu R., Buettner G.R., Oberly L.W. Oxygen free radicals mediate the induction of manganese superoxide gene expression by TNF-alpha. Free Radic Biol Med. 28:2000;1197-1205.
22. Bozkurt B., Kribbs S.B., Clubb F.J. Jr., et al. Pathophysiologically relevant concentrations of tumour necrosis factor-alpha promote progressive left-ventricular dysfunction and remodelling in rats. Circulation. 97:1998;1382-1391.
23. Elasser A., Dicker E., Kostin S., et al. A self perpetuating vicious cycle of tissue damage in human hibernating myocardium. Mol Cell Biochem. 213:2000;17-28.
24. Kim P.K., Zamora R., Petrosko P., et al. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol. 1:2001;1421-1441.
25. Sawyer D.B., Loscalzo J. Myocardial hibernation. Restorative or preterminal sleep? Circulation. 105:2002;1517-1519.
26. Narula J., Arbustini E., Chandrashekar Y., et al. Apoptosic and the systolic dysfunction in congestive heart failure: story of apoptosis interruptus and zombie myocytes. Cardiol Clin. 19:2001;113-126.
27. Yoshida F., Gould K.L. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3 year mortality with and without revascularization. J Am Coll Cardiol. 22:1993;984-997.
28. Deng M.C., Ascheim D.D., Edwards N.M., et al. End stage heart failure: which options? Eur Heart J. 4:(Suppl D):2002;D122-D130.
29. Pfeffer M.A. Left ventricular remodeling after acute myocardial infarction. Annu Rev Med. 46:1995;455-466.
30. Olivetti G., Capasso J.M., Sonneblick E.H., et al. Side to side slippage of myocytes participates in ventricular remodeling acutely myocardial infarction in rats. Circ Res. 67:1990;23-34.
31. Tjan T.D.T., Kondruweit M., Scheld H.H., et al. The bad ventricle - revascularization versus transplantation. J Thorac Cardiovasc Surg. 48:2000;9-14.
32. Blitz A., Laks H. The role of coronary revascularization in the management of heart failure: identification of candidates and review of results. Curr Op Cardiol. 11:1996;276-290.
33. Luciani G.B., Faggani G., Razzaloni R., et al. Severe ischaemic left ventricular failure: coronary operation or heart transplantation? Ann Thorac Surg. 55:1993;719-723.
34. Bax J.J., Poldermans D., Schintel A.F.L., et al. Perfusion and contractile reserve in chronic dysfunctional myocardium: relation to functional outcome after surgical revascularization. Circulation. 106:(Suppl I):2002;I.14-I.18.
35. Blakeman B.M., Pifasse R., Sullivan H., et al. High-risk heart surgery in the heart transplant candidate. J Heart Transplant. 9:1990;468-472.
36. Di Carli M.F., Maddhai J., Rockhsar S., et al. Long term survival of patients with coronary artery disease and left-ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg. 11:1998;997-1004.
37. Louie H.W., Lake A., Milgalter E., et al. Ischaemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation. 84:(Suppl III):1991;290-295.
38. La Canna G., Rahimtoola S.H., Visioli O., et al. Sensitivity, specificity and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J. 21:2000;1358-1367.
39. Roccli G., Poldermass D., Bax J.J., et al. Usefulness of the ejection fraction response to dobutamine infusion in predicting functional recovery after coronary artery bypass grafting in patients with left-ventricular dysfunction. Am J Cardiol. 85:2000;1440-1444.
40. Bonow R.O. Identification of viable myocardium. Circulation. 94:1996;2674-2680.
41. DiCarli M.F., Davidson M., Little R., et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left-ventricular dysfunction. Am J Cardiol. 73:1994;527-533.
42. Vanoverschelde J.-L.J., Berger B.L., D'Handt A.-M., et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Role of low dose dobutamine echocardiography and exercise redistribution-reinjection Thallium SPECT. Circulation. 92:(Suppl II):1995;II.37-II.44.
43. La Canna G., Alfieri O., Giubbini R., et al. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 23:1994;617-626.
44. Edmond M., Mock M.B., Davis K.B., et al. Long term survival of medically treated patients in the coronary artery surgery study (CASS). Circulation. 90:1994;2645-2657.
45. Haas F., Haehnel C.J., Picker W., et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischaemic heart disease. J Am Coll Cardiol. 30:1997;1693-1700.
46. Pagley P.R., Beller G.A., Watson D.D., et al. Improved outcome after coronary artery bypass surgery in patients with ischaemic cardiomyopathy and residual myocardial viability. Circulation. 95:1997;793-800.
47. Mickleborough L.L., Maruyama H., Yasushi T., et al. Results of revascularization in patients with severe left-ventricular dysfunction. Circulation. 92:(Suppl 2):1995;73-79.
48. Bonow R.O. Myocardial viability and prognosis in patients with ischaemic left-ventricular dysfunction. J Am Coll Cardiol. 39:2002;1159-1162.
49. Kaul T.K., Agnihotri A.K., Fields B.L., et al. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg. 111:1996;1001-1012.
50. Dor V., Sabatier M., Di Donato M., et al. Efficacy of endoventricular patch plasty in large post infarction akinetic scar and severe left-ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg. 116:1998;50-59.
51. Jegaden O., Bontemps L., DeGevigney A., et al. Does the extended use of arterial grafts compromise myocardial recovery after coronary artery bypass grafting in left-ventricular dysfunction. Eur J Cardiothorac Surg. 14:1998;353-359.
52. Lansman S.L., Cohen M., Galla J.D., et al. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: long term follow up. Ann Thorac Surg. 56:1993;480-486.
53. Maisano F., Redaelli A., Pennati G., et al. The haemodynamic effects of double orifice valve repair for mitral regurgitation: a 3D computative model. Eur J Cardiothorac Surg. 15:1999;419-425.
54. Bach D.S., Boling S.F. Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end stage cardiomyopathy. Am Heart J. 129:1995;1165-1170.
55. Pasini E., Ferrari G., Cremona G., et al. Revascularization of severe hibernating myocardium in the beating heart: early haemodynamic and metabolic features. Ann Thorac Surg. 71:2001;176-179.
56. Louie H.W., Laks H., Milgate R., et al. Ischaemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation. 84:(Suppl III):1991;III.290-III.295.
57. Haas F., Jennen L., Heinzmann U., et al. Ischemically compromised myocardium different time courses of functional recovery: correlation with morphological alterations. Eur J Cardiothorac Surg. 20:2001;290-298.
58. Arnese M., Cornel J.H., Salustri A., et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201TI single-photon emission computed tomography. Circulation. 91:1995;2748-2752.
59. Allman K.C., Shaw L.J., Hachamovitch R., et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left-ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 39:2002;1151-1158.
60. Randomised Aldactone Evaluation Study (RALES) investigators, Pitt B., Zannad F., Remme W., et al. The effect of spironolactone as morbidity and mortality in patients with severe heart failure. N Eng J Med. 341:1999;709-717.
61. Hausmann H., Topp H., Siniawski H., et al. Decision making in end stage coronary artery disease. Revascularization or heart transplantation. Ann Thorac Surg. 64:1997;1296-1302.
62. Samady H., Elefteriades J.A., Abbot B.G., et al. Failure to improve left ventricular function after coronary revascularization for ischaemic cardiomyopathy is not associated with worse outcome. Circulation. 100:1999;1298-1304.
63. Marwick T., MacIntyre W.J., Lafond A., et al. Metabolic response of hibernating and infracted myocardium to revascularization: a follow up study of perfusion, function and metabolism. Circulation. 85:1992;1347-1353.
64. Bax J.J., Visser F.C., Poldermans D., et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 104:(Suppl I):2001;I.314-I.318.
65. Yamaguchi A., Ino T., Adachi H., et al. Left ventricular volume predicts postoperative course in patients with ischaemic cardiomyopathy. Ann Thorac Surg. 65:1998;434-438.
66. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 343:2000;1445-1453.
67. Maes A., Flameng W., Nuyts J., et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation. 90:1994;735-745.
68. Shan K., Bick R.J., Poindexter B.J., et al. Altered adrenergic receptor density in myocardial hibernation in humans. Circulation. 102:2000;2599-2606.